Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering Ambrisentan

Filters
×

filter

AMBRISENTAN

filter

8377933

9474752

9549926

filter

Blank

filter

Blank

filter

2027-12-11

2031-10-14

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8377933

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2027-12-11

Patent Use Code

U-1754

Delist Requested

Application Number

22081

Patent Use Description

FOR THE TREATMENT OF PULMONARY HYPERTENSION (PAH) IN COMBINATION WITH TADALAFIL

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

9549926

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-10-14

Patent Use Code

U-1965

Delist Requested

Application Number

22081

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8377933

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2027-12-11

Patent Use Code

U-1754

Delist Requested

Application Number

22081

Patent Use Description

FOR THE TREATMENT OF PULMONARY HYPERTENSION (PAH) IN COMBINATION WITH TADALAFIL

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

9474752

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2027-12-11

Patent Use Code

U-1754

Delist Requested

Application Number

22081

Patent Use Description

FOR THE TREATMENT OF PULMONARY HYPERTENSION (PAH) IN COMBINATION WITH TADALAFIL

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

9549926

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-10-14

Patent Use Code

U-1965

Delist Requested

Application Number

22081

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

9474752

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2027-12-11

Patent Use Code

U-1754

Delist Requested

Application Number

22081

Patent Use Description

FOR THE TREATMENT OF PULMONARY HYPERTENSION (PAH) IN COMBINATION WITH TADALAFIL

Product Number

2

PharmaCompass >>

First
Previous
Next
Last